Survey of U.S. Neurologists' Attitudes Towards Deep Brain Stimulation for Parkinson's Disease
Identifieur interne : 000145 ( Main/Exploration ); précédent : 000144; suivant : 000146Survey of U.S. Neurologists' Attitudes Towards Deep Brain Stimulation for Parkinson's Disease
Auteurs : Ludy C. Shih ; Daniel Tarsy [États-Unis]Source :
- Neuromodulation: Technology at the Neural Interface [ 1094-7159 ] ; 2011-05.
English descriptors
- KwdEn :
Abstract
Objectives: Deep brain stimulation (DBS) for Parkinson's disease (PD) was approved by the Food and Drug Administration in 2002 and has demonstrated clinical benefit in advanced PD. Our aim was to assess attitudes of U.S. neurologists towards the role of DBS in management of advanced PD. Materials and Methods: We sent a 40‐item Internet‐based survey assessing opinions regarding the role of medical and surgical therapies in managing PD to 7722 neurologists in the American Medical Association Physician MasterFile data base. Results: The response rate was low (4.2%). In total, 78 of the 298 (26%) responders self‐identified as movement disorders specialists. Specialists and non‐specialists had differences on a number of medical strategies used to manage PD. There were no statistically significant differences in reasons for or against referring patients for DBS, except for the number of non‐specialists who agreed with referring a patient who had a “poor or absent response to levodopa” (71% vs. 16%, p < 0.001). Both groups indicated a need for more information concerning appropriate indications for DBS, adverse effects of surgery, and postoperative programming. Conclusions: Movement disorders specialists and non‐specialists were in general agreement towards the beneficial role of DBS in management of advanced PD except for whether to refer patients with poor or absent response to levodopa.
Url:
DOI: 10.1111/j.1525-1403.2011.00350.x
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Survey of U.S. Neurologists' Attitudes Towards Deep Brain Stimulation for Parkinson's Disease</title><author><name sortKey="Shih, Ludy C" sort="Shih, Ludy C" uniqKey="Shih L" first="Ludy C." last="Shih">Ludy C. Shih</name></author><author><name sortKey="Tarsy, Daniel" sort="Tarsy, Daniel" uniqKey="Tarsy D" first="Daniel" last="Tarsy">Daniel Tarsy</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:1D9EE26C5DEE702DF5350DF8351846544D65813F</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1111/j.1525-1403.2011.00350.x</idno><idno type="url">https://api.istex.fr/document/1D9EE26C5DEE702DF5350DF8351846544D65813F/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">001724</idno><idno type="wicri:Area/Main/Curation">001488</idno><idno type="wicri:Area/Main/Exploration">000145</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Survey of U.S. Neurologists' Attitudes Towards Deep Brain Stimulation for Parkinson's Disease</title><author><name sortKey="Shih, Ludy C" sort="Shih, Ludy C" uniqKey="Shih L" first="Ludy C." last="Shih">Ludy C. Shih</name></author><author><name sortKey="Tarsy, Daniel" sort="Tarsy, Daniel" uniqKey="Tarsy D" first="Daniel" last="Tarsy">Daniel Tarsy</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, National Parkinson Foundation Center of Excellence, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Neuromodulation: Technology at the Neural Interface</title><idno type="ISSN">1094-7159</idno><idno type="eISSN">1525-1403</idno><imprint><publisher>Blackwell Publishing Inc</publisher><pubPlace>Malden, USA</pubPlace><date type="published" when="2011-05">2011-05</date><biblScope unit="volume">14</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="208">208</biblScope><biblScope unit="page" to="213">213</biblScope></imprint><idno type="ISSN">1094-7159</idno></series><idno type="istex">1D9EE26C5DEE702DF5350DF8351846544D65813F</idno><idno type="DOI">10.1111/j.1525-1403.2011.00350.x</idno><idno type="ArticleID">NER350</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1094-7159</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Deep brain stimulation</term><term>Parkinson's disease</term><term>patient selection</term><term>prospective nonrandomized study</term><term>subthalamic nucleus</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Objectives: Deep brain stimulation (DBS) for Parkinson's disease (PD) was approved by the Food and Drug Administration in 2002 and has demonstrated clinical benefit in advanced PD. Our aim was to assess attitudes of U.S. neurologists towards the role of DBS in management of advanced PD. Materials and Methods: We sent a 40‐item Internet‐based survey assessing opinions regarding the role of medical and surgical therapies in managing PD to 7722 neurologists in the American Medical Association Physician MasterFile data base. Results: The response rate was low (4.2%). In total, 78 of the 298 (26%) responders self‐identified as movement disorders specialists. Specialists and non‐specialists had differences on a number of medical strategies used to manage PD. There were no statistically significant differences in reasons for or against referring patients for DBS, except for the number of non‐specialists who agreed with referring a patient who had a “poor or absent response to levodopa” (71% vs. 16%, p < 0.001). Both groups indicated a need for more information concerning appropriate indications for DBS, adverse effects of surgery, and postoperative programming. Conclusions: Movement disorders specialists and non‐specialists were in general agreement towards the beneficial role of DBS in management of advanced PD except for whether to refer patients with poor or absent response to levodopa.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Massachusetts</li></region></list><tree><noCountry><name sortKey="Shih, Ludy C" sort="Shih, Ludy C" uniqKey="Shih L" first="Ludy C." last="Shih">Ludy C. Shih</name></noCountry><country name="États-Unis"><region name="Massachusetts"><name sortKey="Tarsy, Daniel" sort="Tarsy, Daniel" uniqKey="Tarsy D" first="Daniel" last="Tarsy">Daniel Tarsy</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000145 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000145 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:1D9EE26C5DEE702DF5350DF8351846544D65813F
|texte= Survey of U.S. Neurologists' Attitudes Towards Deep Brain Stimulation for Parkinson's Disease
}}
| This area was generated with Dilib version V0.6.23. |  |